Latest & greatest articles for dementia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on dementia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on dementia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for dementia

481. Galantamine for dementia in people with Down syndrome. (Abstract)

Galantamine for dementia in people with Down syndrome. Alzheimer's dementia (AD) is the most common form of dementia in people with Down Syndrome (DS). Acetylcholine is a chemical found in the brain that has an important role in memory, attention, reason and language. Galantamine both inhibits the activity of acetylcholinesterase and increases the level of acetylcholine. Galantamine can improve cognitive function and slow the decline of AD in the general population over time. It is important

2009 Cochrane

482. Rivastigmine for dementia in people with Down syndrome. (Abstract)

Rivastigmine for dementia in people with Down syndrome. Alzheimer's dementia (AD) is the most common form of dementia in people with Down Syndrome (DS). Acetylcholine is a chemical found in the brain that has an important role in memory, attention, reason and language. Rivastigmine is a "pseudo-irreversible" inhibitor of acetylcholinesterase, which is thought to maintain levels of acetylcholine. Rivastigmine can improve cognitive function and slow the decline of AD in the general population

2009 Cochrane

483. Driving assessment for maintaining mobility and safety in drivers with dementia. Full Text available with Trip Pro

Driving assessment for maintaining mobility and safety in drivers with dementia. Demographic changes are leading to an increase in the number of older drivers: as dementia is an age-related disease, there is also an increase in the numbers of drivers with dementia. Dementia can impact on both the mobility and safety of drivers, and the impact of formal assessment of driving is unknown in terms of either mobility or safety. Those involved in assessment of older drivers need to be aware (...) a crash.1. To assess whether driving assessment facilitates continued driving in people with dementia 2. To assess whether driving assessment reduces accidents in people with dementia.To assess the quality of research on assessment of drivers with dementia.The Cochrane Dementia Group's Specialized Register was searched on 30 October 2007 using the terms: driving or driver* or "motor vehicle*" or "car accident*" or "traffic accident*" or automobile* or traffic. This register contains records from major

2009 Cochrane

484. Clinical and cost effectiveness of services for early diagnosis and intervention in dementia Full Text available with Trip Pro

Clinical and cost effectiveness of services for early diagnosis and intervention in dementia Clinical and cost effectiveness of services for early diagnosis and intervention in dementia Clinical and cost effectiveness of services for early diagnosis and intervention in dementia Banerjee S, Wittenberg R Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results (...) and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The objective was to assess the costs and benefits associated with a memory service for early diagnosis and intervention for people with dementia. The authors concluded that, based on the best available evidence, there was a case for the development of a nationwide service for early diagnosis and intervention in dementia. Overall, there were some limitations to the study, so

2009 NHS Economic Evaluation Database.

485. Ginkgo biloba does not reduce incidence of dementia in elderly people

Ginkgo biloba does not reduce incidence of dementia in elderly people Ginkgo biloba does not reduce incidence of dementia in elderly people | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username (...) * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Ginkgo biloba does not reduce incidence of dementia in elderly people Article Text Therapeutics Ginkgo biloba does not reduce incidence of dementia in elderly people Statistics from Altmetric.com QUESTION Question: Does Ginkgo biloba reduce

2009 Evidence-Based Mental Health

486. Insufficient evidence for benefit of enteral tube feeding for older people with advanced dementia

Insufficient evidence for benefit of enteral tube feeding for older people with advanced dementia PEARLS Practical Evidence About Real Life Situations PEARLS are succinct summaries of Cochrane Systematic Reviews for primary care practitioners. They Insufficient evidence for benefit of enteral tube feeding for older people with advanced dementia Clinical question How effective is enteral tube feeding for older people with advanced dementia? Bottom line Despite the large number of patients (...) receiving this intervention, there is insufficient evidence for the effectiveness of enteral tube feeding for older people with advanced dementia in terms of survival, quality of life, nutrition and pressure ulcers, function and behavioural or psychiatric symptoms of dementia. Data are lacking on the adverse effects of this intervention. Caveat None of the studies reported comparability on a range of key characteristics between the intervention group and the comparison group. All studies were further

2009 Cochrane PEARLS

487. No evidence of benefit from cannabinoids in dementia

No evidence of benefit from cannabinoids in dementia PEARLS Practical Evidence About Real Life Situations PEARLS are succinct summaries of Cochrane Systematic Reviews for primary care practitioners. They No evidence of benefit from cannabinoids in dementia Clinical question Are cannabinoids clinically effective in the treatment of dementia? Bottom line There was no evidence that cannabinoids are effective in the improvement of disturbed behaviour in dementia or in the treatment of other (...) symptoms of dementia. Only 1 small study was included which was designed to focus on the effects of the cannabinoid dronabinol on anorexia in Alzheimer's disease. While improvement of anorexia is clearly an important outcome for patients and their carers, it was not a primary outcome of interest in this review. The study concluded that the cannabinoid dronabinol may be useful in the treatment of anorexia and to improve disturbed behaviour in people with Alzheimer's disease. Caveat Only 1 small study

2009 Cochrane PEARLS

488. No evidence for statins preventing dementia

No evidence for statins preventing dementia PEARLS Practical Evidence About Real Life Situations PEARLS are succinct summaries of Cochrane Systematic Reviews for primary care practitioners. They No evidence for statins preventing dementia Clinical question Do statins prevent dementia? Bottom line There is good evidence statins given in late life to individuals at risk of vascular disease have no effect in preventing Alzheimer's disease (AD) and dementia. The age range of participants was 40-82 (...) years across the 2 studies. Caveat Cognition was measured at different times and with different scales in the 2 studies so could not be combined in a metaanalysis. The mean follow-up period was 3.2 years in 1 study and 5 years in the other. Context PAD is the most common form of dementia affecting up to 15 million individuals worldwide. AD has a prevalence of approximately 1% among 60 to 64-year-olds, rising to 40% in those age 85 years and older. Biologically it seems feasible statins could prevent

2009 Cochrane PEARLS

489. No evidence for benefit of procaine in prevention or treatment of dementia

No evidence for benefit of procaine in prevention or treatment of dementia PEARLS Practical Evidence About Real Life Situations PEARLS are succinct summaries of Cochrane Systematic Reviews for primary care practitioners. They No evidence for benefit of procaine in prevention or treatment of dementia Clinical question How effective is procaine on cognitive function in the treatment of people with dementia, and for healthy elderly people? Bottom line There is some evidence from older studies (...) that procaine preparations might improve memory in people without cognitive impairment. However, the evidence for detrimental effects of procaine and its preparations is stronger than the evidence for benefits in preventing and/or treating dementia or cognitive impairment. There were few adverse events related to long term use of procaine but some were serious (migraine, systemic lupus erythematosus syndrome). Caveat Meta-analysis of beneficial outcomes was not appropriate due to the different preparations

2009 Cochrane PEARLS

490. Review: long-term annual conversion rate to dementia was 3.3% in elderly people with mild cognitive impairment

Review: long-term annual conversion rate to dementia was 3.3% in elderly people with mild cognitive impairment Review: long-term annual conversion rate to dementia was 3.3% in elderly people with mild cognitive impairment | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: long-term annual conversion rate to dementia was 3.3% in elderly people with mild cognitive impairment Article Text Prognosis Review: long-term annual

2009 Evidence-Based Medicine

491. Ginkgo biloba did not prevent dementia or Alzheimer disease in elderly people Full Text available with Trip Pro

Ginkgo biloba did not prevent dementia or Alzheimer disease in elderly people Ginkgo biloba did not prevent dementia or Alzheimer disease in elderly peopleCommentary | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional (...) accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Ginkgo biloba did not prevent dementia or Alzheimer disease in elderly peopleCommentary Article Text Treatment Ginkgo biloba did not prevent dementia or Alzheimer disease in elderly people Commentary Free Gareth Parsons

2009 Evidence-Based Nursing

492. Starting a conventional antipsychotic increases risk of death more than an atypical antipsychotic in elderly people with dementia

Starting a conventional antipsychotic increases risk of death more than an atypical antipsychotic in elderly people with dementia Starting a conventional antipsychotic increases risk of death more than an atypical antipsychotic in elderly people with dementia | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our (...) . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Starting a conventional antipsychotic increases risk of death more than an atypical antipsychotic in elderly people with dementia

2009 Evidence-Based Mental Health

493. Elderly women with larger social networks are less likely to develop dementia Full Text available with Trip Pro

Elderly women with larger social networks are less likely to develop dementia Elderly women with larger social networks are less likely to develop dementia | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts (...) Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Elderly women with larger social networks are less likely to develop dementia Article Text Aetiology Elderly women with larger social networks are less likely to develop dementia Statistics from Altmetric.com QUESTION Question

2009 Evidence-Based Mental Health

494. Short term use of antipsychotics increases the risk of serious adverse events in elderly people with dementia

Short term use of antipsychotics increases the risk of serious adverse events in elderly people with dementia Short term use of antipsychotics increases the risk of serious adverse events in elderly people with dementia | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Short term use of antipsychotics increases the risk of serious adverse events in elderly people with dementia Article Text Aetiology Short term use of antipsychotics

2009 Evidence-Based Mental Health

495. Herbal medicine for dementia: a systematic review

Herbal medicine for dementia: a systematic review Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

496. A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment

A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

497. Psychosocial treatments of behavior symptoms in dementia: a systematic review of reports meeting quality standards

Psychosocial treatments of behavior symptoms in dementia: a systematic review of reports meeting quality standards Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

498. Psychosocial treatments of psychological symptoms in dementia: a systematic review of reports meeting quality standards

Psychosocial treatments of psychological symptoms in dementia: a systematic review of reports meeting quality standards Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

499. Can cognitive exercise prevent the onset of dementia? Systematic review of randomized clinical trials with longitudinal follow-up

Can cognitive exercise prevent the onset of dementia? Systematic review of randomized clinical trials with longitudinal follow-up Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

500. Cognitive leisure activities and their role in preventing dementia: a systematic review

Cognitive leisure activities and their role in preventing dementia: a systematic review Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.